Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus

Diseases of the Esophagus

Volumn 20, Issue 3, 2007, Pages 265-268

  Jacobson, Glenn A ^a   Narkowicz, C ^a   Lord, R ^a   Howard, B J ^a   Chung, S ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

Barrett's esophagus; Celecoxib; COX 2; Cyclooxygenase 2

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2; DNA; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BARRETT ESOPHAGUS; CASE REPORT; CHEMOLUMINESCENCE; DNA FINGERPRINTING; ENDOSCOPIC BIOPSY; ESOPHAGOSCOPY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNODETECTION; IN VIVO STUDY; LONG TERM EXPOSURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ADULT; BARRETT ESOPHAGUS; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; PYRAZOLES; SULFONAMIDES;

EID: 34249671638     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00684.x     Document Type: Article

References (10)

1. Buskens C J, Van Rees B P, Sivula A et al. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 2002; 122: 1800-7.
2. Shirvani V N, Ouatu-Lascar R, Kaur B S, Omary M B, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 2000; 118: 487-96.
3. Cheong E, Igali L, Harvey I et al. Cyclo-oxygenase-2 expression in Barrett's oesophageal carcinogenesis: An immunohistochemical study. Aliment Pharmacol Ther 2003; 17: 379-86.
4. Souza R F, Shewmake K, Beer D G, Cryer B, Spechler S J. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 2000; 60: 5767-72.
5. Kaur B S, Khamnehei N, Iravani M, Namburu S S, Lin O, Triadafilopoulos G. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. Gastroenterology 2002; 123: 60-7.
6. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
7. Roos K L, Simmons D L. Cyclooxygenase variants: The role of alternative splicing. Biochem Biophys Res Commun 2005; 338: 62-9.
8. Censarek P, Freidel K, Udelhoven M et al. Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting. Thromb Haemost 2004; 92: 925-8.
9. Huang Y, Ye D, Wu P et al. Expression of cyclooxygenase-2 mRNA and identification of its splice variant in human myometrium obtained from women in labor. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 5-7.
10. Anonymous. COX-2 monoclonal antibody. Cayman Chemical 2003; Ann Arbor (Product information 160112).